Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Investigation

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI57834PMID 21785218PMCID PMC3148747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

  2011cited by this paper
• Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

  2011cited by this paper
• Plasmablast-derived polyclonal antibody response after influenza vaccination.

  2011cited by this paper
• Aging Affects Human B Cell Responses

  2011cited by this paper
• Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

  2010cited by this paper
• Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation.

  2010cited by this paper
• Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus

  2010cited by this paper
• Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

  2010cited by this paper
• Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

  2009cited by this paper
• Vaccination in the elderly: an immunological perspective.

  2009cited by this paper
• Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen

  2009cited by this paper
• B cells and aging: molecules and mechanisms.

  2009cited by this paper
• B-cell responses to vaccination at the extremes of age

  2009cited by this paper
• Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

  2008cited by this paper
• Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

  2008cited by this paper
• Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses

  2008cited by this paper
• Aging Down-Regulates the Transcription Factor E2A, Activation-Induced Cytidine Deaminase, and Ig Class Switch in Human B Cells1

  2008cited by this paper
• Mechanisms for Decreased Function of B Cells in Aged Mice and Humans1

  2008cited by this paper
• Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2008cited by this paper
• Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

  2007cited by this paper
• Decreased expression of Krüppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses

  2007cited by this paper
• Correction of age-associated deficiency in germinal center response by immunization with immune complexes.

  2007cited by this paper
• An Introduction to the Bootstrap

  2007cited by this paper
• Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.

  2007cited by this paper
• Antibody response to influenza vaccination in the elderly: a quantitative review.

  2006cited by this paper
• Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus Vaccines

  2006cited by this paper
• Immune Response to Pneumococcal Polysaccharides 4 and 14 in Elderly and Young Adults: Analysis of the Variable Heavy Chain Repertoire

  2005cited by this paper
• Rectification of age-related impairment in Ig gene hypermutation during a memory response.

  2004cited by this paper
• Antibody diversity: one enzyme to rule them all

  2004cited by this paper
• Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines

  2004cited by this paper
• A Randomized Double-blind Placebo-controlled Trial

  2004cited by this paper
• Age-related Defects in CD4 T Cell Cognate Helper Function Lead to Reductions in Humoral Responses

  2004cited by this paper
• Intrinsic Differences in the Proliferation of Naive and Memory Human B Cells as a Mechanism for Enhanced Secondary Immune Responses1

  2003cited by this paper
• Plasma-cell homing

  2003cited by this paper
• Predominant Autoantibody Production by Early Human B Cell Precursors

  2003cited by this paper
• Effects of aging on proliferation and E47 transcription factor activity induced by different stimuli in murine splenic B cells.

  2003cited by this paper
• Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells

  2002cited by this paper
• Chemokines and the tissue-specific migration of lymphocytes.

  2002cited by this paper
• The role of the antibody response in influenza virus infection.

  2001cited by this paper
• Avidity, Potency, and Cross-Reactivity of Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide Serotype 6B

  2001cited by this paper
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• Immune function and vaccine responses in healthy advanced elderly patients.

  2000cited by this paper
• Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.

  1999cited by this paper
• Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides

  1999cited by this paper
• Prevention and control of influenza.

  1999cited by this paper
• Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination.

  1998cited by this paper
• Immunosenescence and germinal center reaction

  1997cited by this paper
• The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.

  1994cited by this paper
• The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial

  1994cited by this paper
• An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination.

  1994cited by this paper
• Address Correspondence To

  1991cited by this paper
• The structural relationship: regression in biology

  1988cited by this paper
• A class of distributions which includes the normal ones

  1985cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper

• Dynamics of lung-infiltrating virus-specific T cells associated with age-dependent SARS-CoV-2 pneumonia severity

  2026cites this paper
• Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design

  2026cites this paper
• Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets.

  2026cites this paper
• When estrogen deficiency meets immune responses induced by rabies vaccination

  2025cites this paper
• Immunological biomarkers of aging

  2025cites this paper
• An RNA replicon vaccine encoding HA and NA prevents shedding of antigen-drifted 2009 pandemic H1N1 influenza virus in the pig model

  2025cites this paper
• Predicting influenza vaccine-elicited antibody responses with practical point systems.

  2025cites this paper
• A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older.

  2025cites this paper
• The recent advances in vaccine adjuvants

  2025cites this paper
• A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults

  2025cites this paper
• Elicitation of protective immune responses against influenza a viruses in elderly ferrets by adjuvanted recombinant universal influenza hemagglutinin vaccines

  2025cites this paper
• Human immune aging.

  2025cites this paper
• Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice

  2025cites this paper
• A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.

  2025cites this paper
• The inflammaging microenvironment induces dysfunctional rewiring of Tfh cell differentiation

  2025cites this paper
• ВОЗРАСТНЫЕ ИЗМЕНЕНИЯ В ИММУННОЙ СИСТЕМЕ ПРИ СТАРЕНИИ ОРГАНИЗМА

  2024cites this paper
• Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice.

  2024cites this paper
• Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges

  2024cites this paper
• Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50-75 years: a phase 1/2, open-label, randomised trial.

  2024cites this paper
• Detection of HHV-5 HHV-6a HHV-6b and HHV-7 in the urine: potential use as a non-invasive diagnostic tool for immune profiling

  2024cites this paper
• Estradiol mediates greater germinal center responses to influenza vaccination in female than male mice

  2024cites this paper
• Enhanced mitochondrial function in B cells from elderly type-2 diabetes mellitus patients supports intrinsic inflammation

  2024cites this paper
• High-throughput single-cell profiling of B cell responses following inactivated influenza vaccination in young and older adults

  2023cites this paper
• Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination

  2023cites this paper
• Vaccine adjuvants: mechanisms and platforms

  2023cites this paper
• Dietary supplementation with spray-dried animal plasma improves vaccine protection in aged mice

  2023cites this paper
• Human Metapneumovirus Reinfection in Aged Mice Recapitulates Increased Disease Severity in Elderly Humans Infected with Human Metapneumovirus

  2023cites this paper
• Effect of DMARDs on the immunogenicity of vaccines

  2023cites this paper
• Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults

  2023cites this paper
• Modeling human immune responses to vaccination in vitro.

  2023cites this paper
• The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease

  2023cites this paper
• Sex differences in microglia function in aged rats underlie vulnerability to cognitive decline.

  2023cites this paper
• Vaccine-Preventable Diseases in Older Adults.

  2023cites this paper
• Contribution of viral and bacterial infections to senescence and immunosenescence

  2023cites this paper
• The Function of Memory CD8+ T Cells in Immunotherapy for Human Diseases

  2023cites this paper
• SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from the University Hospital in Krakow, Poland

  2023cites this paper
• COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review

  2023cites this paper
• Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor

  2023cites this paper
• Estradiol Mediates Greater Germinal Center Responses to Influenza Vaccination in Female than Male Mice

  2023cites this paper
• Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice

  2023cites this paper
• Pre‐vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination

  2023cites this paper
• Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine

  2022cites this paper
• Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine

  2022cites this paper
• A Review on Equine Influenza from a Human Influenza Perspective

  2022cites this paper
• Age-related ocular surface failure: A narrative review.

  2022cites this paper
• An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly.

  2022cites this paper
• Impact of Diet and Lifestyle on Vaccine Efficacy in Adults Aged 55 and Older: A Review.

  2022cites this paper
• Extensive age-dependent loss of antibody diversity in naturally short-lived turquoise killifish

  2022cites this paper
• Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine

  2022cites this paper
• Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly

  2022cites this paper
• MODELING OF IMMUNOSENESCENCE WITH AGING IN SYSTEMIC LUPUS ERYTHEMATOSUS

  2022cites this paper
• Frailty and Age Impact Immune Responses to Moderna COVID-19 mRNA Vaccine

  2022cites this paper
• Generation of a single-cell B cell atlas of antibody repertoires and transcriptomes to identify signatures associated with antigen specificity

  2022cites this paper
• Human lymph node immune dynamics as driver of vaccine efficacy: an understudied aspect of immune responses

  2022cites this paper
• Effect of Cytomegalovirus on the Immune System: Implications for Aging and Mental Health.

  2022cites this paper
• Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory

  2022cites this paper
• Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study

  2022cites this paper
• Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.

  2021cites this paper
• Age‐related changes in ocular mucosal tolerance: Lessons learned from gut and respiratory tract immunity

  2021cites this paper
• Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma

  2021cites this paper
• Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program

  2021cites this paper
• BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection

  2021cites this paper
• Vaccine responses in ageing and chronic viral infection

  2021cites this paper
• B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

  2021cites this paper
• Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays

  2021cites this paper
• Are the Healthy Vulnerable? Cytomegalovirus Seropositivity in Healthy Adults Is Associated With Accelerated Epigenetic Age and Immune Dysregulation

  2021cites this paper
• Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2

  2021cites this paper
• Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants

  2021cites this paper
• Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales

  2021cites this paper
• Mechanisms underpinning poor antibody responses to vaccines in ageing

  2021cites this paper
• Emerging concepts in the science of vaccine adjuvants

  2021cites this paper
• Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness

  2021cites this paper
• Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention

  2021cites this paper
• The aging lung: Physiology, disease, and immunity

  2021cites this paper
• Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study

  2021cites this paper
• Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes

  2021cites this paper
• Terminally Differentiated CD4+ T Cells Promote Myocardial Inflammaging

  2021influential citation
• Human Coronaviruses: Counteracting the Damage by Storm

  2021cites this paper
• Tissues: the unexplored frontier of antibody mediated immunity.

  2021cites this paper
• The ocular surface immune system through the eyes of aging.

  2021cites this paper
• IL-21 enhances influenza vaccine responses in aged macaques with suppressed SIV infection

  2021cites this paper
• Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination

  2021cites this paper
• Age-related changes in the TRB and IGH repertoires in healthy adult males and females.

  2021cites this paper
• Aging and Options to Halt Declining Immunity to Virus Infections

  2021cites this paper
• Metformin Enhances B Cell Function and Antibody Responses of Elderly Individuals With Type-2 Diabetes Mellitus

  2021cites this paper
• Decreased vaccine protection of egg-based influenza vaccine in the elderly and nonhemagglutinin-focused immunity.

  2021cites this paper
• Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine

  2021cites this paper
• Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination

  2021cites this paper
• Age-dependent immune response to the 1 Biontech/Pfizer BNT162b2 COVID-19 2 vaccination 3

  2021cites this paper
• Understanding immunosenescence and its impact on vaccination of older adults.

  2020cites this paper
• Epidemiology of viral respiratory infections with focus on in-hospital influenza transmission

  2020cites this paper
• Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination

  2020cites this paper
• Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.

  2020cites this paper
• Antibody repertoire sequencing reveals systemic and mucosal immunosenescence in the short-lived turquoise killifish

  2020cites this paper
• B Cell Immunosenescence.

  2020cites this paper
• The Prevention of Infections in Older Adults: Vaccination

  2020cites this paper
• Immunotherapy in older patients with cancer

  2020cites this paper
• Analysis of immune cells and vaccine antibody response in humans after thymectomy

  2020cites this paper
• Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury

  2020cites this paper
• Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus

  2020cites this paper